FI955051A0 - Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö - Google Patents

Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö

Info

Publication number
FI955051A0
FI955051A0 FI955051A FI955051A FI955051A0 FI 955051 A0 FI955051 A0 FI 955051A0 FI 955051 A FI955051 A FI 955051A FI 955051 A FI955051 A FI 955051A FI 955051 A0 FI955051 A0 FI 955051A0
Authority
FI
Finland
Prior art keywords
preparation
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
FI955051A
Other languages
English (en)
Swedish (sv)
Other versions
FI955051A (fi
Inventor
Charles Arthur Alt
Leander Nmn Merritt
Charles Howard Mitch
Gary Anthony Rhodes
Roger Lewis Robey
Meter Eldon Eugene Van
John Stanley Ward
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI955051A0 publication Critical patent/FI955051A0/fi
Publication of FI955051A publication Critical patent/FI955051A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FI955051A 1994-10-24 1995-10-23 Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö FI955051A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32776694A 1994-10-24 1994-10-24
US44367395A 1995-06-01 1995-06-01

Publications (2)

Publication Number Publication Date
FI955051A0 true FI955051A0 (fi) 1995-10-23
FI955051A FI955051A (fi) 1996-04-25

Family

ID=26986055

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955051A FI955051A (fi) 1994-10-24 1995-10-23 Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö

Country Status (21)

Country Link
US (6) US5821370A (fi)
EP (1) EP0709381A1 (fi)
JP (1) JPH08225575A (fi)
KR (1) KR960014125A (fi)
CN (1) CN1048986C (fi)
AU (1) AU705047B2 (fi)
BR (1) BR9504509A (fi)
CA (1) CA2161176A1 (fi)
CO (1) CO4480103A1 (fi)
CZ (1) CZ275995A3 (fi)
FI (1) FI955051A (fi)
HU (1) HUT76347A (fi)
IL (1) IL115717A0 (fi)
NO (1) NO306949B1 (fi)
NZ (1) NZ280300A (fi)
PE (1) PE12697A1 (fi)
PL (1) PL311077A1 (fi)
RU (1) RU2158262C2 (fi)
TR (1) TR199501305A2 (fi)
TW (1) TW420680B (fi)
YU (1) YU66895A (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US6040442A (en) * 1995-06-01 2000-03-21 Eli Lilly And Company Process for preparing 1,2,5-thiadiazole containing ethers
US5767280A (en) * 1995-06-01 1998-06-16 Eli Lilly And Company Process for making heterocyclic compounds
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
EP0888355A1 (en) * 1996-03-19 1999-01-07 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
JP2000509046A (ja) * 1996-04-23 2000-07-18 イーライ・リリー・アンド・カンパニー ヘテロサイクリック化合物群
CA2252527A1 (en) 1996-04-23 1997-10-30 Lone Jeppesen Heterocyclic compounds
CA2250472A1 (en) * 1996-04-23 1997-10-30 Steven James Quimby Heterocyclic compounds
AU2679497A (en) * 1996-04-23 1997-11-12 Eli Lilly And Company Heterocyclic compounds
EP0912183A4 (en) * 1996-04-23 1999-08-04 Lilly Co Eli HETEROCYCLIC COMPOSITIONS
US6069159A (en) * 1996-05-10 2000-05-30 Eli Lilly And Company Heterocyclic compounds
DK0821955T3 (da) * 1996-08-01 2002-03-18 Lilly Co Eli Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse
AU7871498A (en) * 1996-12-20 1998-07-17 Novo Nordisk A/S A method of treating hypercholesterolemia and related disorders
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6620940B1 (en) 1998-08-20 2003-09-16 Eli Lilly And Company Palladium-catalyzed cross-coupling chemistry on 3-chloro-4-halo-1,2,5-thiadiazole
WO2000075140A1 (en) * 1999-06-04 2000-12-14 Eli Lilly And Company 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
US6392329B1 (en) * 1999-10-12 2002-05-21 Face International Corp. Piezoelectric vibrating apparatus
US20050245567A1 (en) * 2002-08-14 2005-11-03 Dan Peters Novel quinuclidine derivatives and their use
CA2501575A1 (en) * 2002-10-08 2004-04-22 The Scripps Research Institute Inhibitors of fatty acid amide hydrolase
WO2004113297A2 (en) * 2003-06-24 2004-12-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2005016923A1 (en) * 2003-08-13 2005-02-24 Neurosearch A/S Novel quinuclidine derivatives and their pharmaceutical use
US7241773B2 (en) 2003-12-22 2007-07-10 Abbott Laboratories 3-quinuclidinyl heteroatom bridged biaryl derivatives
US7309699B2 (en) 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
US20050137203A1 (en) * 2003-12-22 2005-06-23 Jianguo Ji 3-quinuclidinyl amino-substituted biaryl derivatives
US20050137398A1 (en) * 2003-12-22 2005-06-23 Jianguo Ji 3-Quinuclidinyl heteroatom bridged biaryl derivatives
WO2005075479A1 (en) * 2004-02-04 2005-08-18 Neurosearch A/S Dimeric azacyclic compounds and their use
EP1831220A2 (en) * 2004-12-20 2007-09-12 Eli Lilly &amp; Company Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20080078081A1 (en) * 2006-09-28 2008-04-03 Huff Philip A High pressure-rated ram blowout preventer and method of manufacture
US20080105340A1 (en) * 2006-11-02 2008-05-08 Huff Philip A Heat Treatment Method of Inlaid Pressure Vessels
US7721401B2 (en) * 2006-09-28 2010-05-25 Hydril Usa Manufacturing Llc Reinforcement of irregular pressure vessels
US7849599B2 (en) * 2006-09-28 2010-12-14 Hydril Usa Manufacturing Llc Imputing strength gradient in pressure vessels
US20080105341A1 (en) * 2006-11-02 2008-05-08 Huff Philip A Heat treatment of inlaid pressure vessels
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
AU2008326360A1 (en) * 2007-11-21 2009-05-28 Abbott Laboratories Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
WO2012040404A1 (en) 2010-09-23 2012-03-29 Abbott Laboratories Monohydrate of an azaadamantane derivative
AU2013212209A1 (en) * 2012-01-25 2014-06-26 Demerx, Inc. (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
MX2018000202A (es) 2015-07-02 2018-06-27 Horizon Orphan Llc Analogos de cisteamina resistentes a la ado y sus usos.

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247193A (en) * 1966-04-19 And the preparatpdn
US3419573A (en) * 1965-10-15 1968-12-31 Merck & Co Inc 3-chloro-4-oxy-1,2,5-thiadiazoles, and a process for preparing same
US3488360A (en) * 1966-08-01 1970-01-06 Merck & Co Inc 1,2,5-thiadiazoles and methods for preparing same
AT266827B (de) * 1966-11-14 1968-12-10 Chemie Linz Ag Verfahren zur Herstellung von neuen Derivaten des 3-Amino-1,2,5-thiadiazols
AT281018B (de) * 1968-04-03 1970-05-11 Chemie Linz Ag Verfahren zur Herstellung von 3-Amino-4-brom-1,2,5-thiadiazol
GB1253709A (en) * 1968-05-22 1971-11-17 Frosst & Co Charles E Thiadiazole derivatives
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DE1914496C3 (de) * 1969-03-21 1974-08-01 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Verfahren zur Herstellung von 1,2,5 -Thiadiazolderivaten
US3619370A (en) * 1969-04-21 1971-11-09 Frosst & Co Charles E Microbial reduction of thiadiazoles
AT294081B (de) * 1969-09-18 1971-11-10 Chemie Linz Ag Verfahren zur Herstellung von Sulfanilamido-1,2,5,-thiadiazolderivaten
NL7109460A (fi) * 1970-07-22 1972-01-25
US3729477A (en) * 1971-09-09 1973-04-24 Frosst & Co Charles E Certain 4-(3-amino-2-hydroxypropoxy)-1,2,5-thiadiazole-3-carboxamides
JPS4913176A (fi) * 1972-06-03 1974-02-05
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
US4508725A (en) * 1982-12-22 1985-04-02 American Hospital Supply Corporation Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
CA1307790C (en) * 1987-08-04 1992-09-22 Ian Anthony Cliffe Ethers
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5482916A (en) * 1989-08-22 1996-01-09 Tosoh Corporation Thiadiazole derivatives and herbicide compositions containing same
EP0414511A1 (en) * 1989-08-22 1991-02-27 Tosoh Corporation Thiadiazole derivatives and herbicide compositions containing the same
ATE108448T1 (de) * 1990-05-11 1994-07-15 Sankyo Co Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung.
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
JPH04182403A (ja) * 1990-11-16 1992-06-30 Tosoh Corp チアジアゾール誘導体を有効成分として含有する殺菌剤
US5051420A (en) * 1991-03-04 1991-09-24 A. H. Robins Company, Incorporated 4-substituted-3-1H-imidazol-1-,2,5-thiadiazoles as antiarrhythmic agents
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
AU3886493A (en) * 1992-04-22 1993-11-18 Karin Elisabeth Peuschel Immuno-activating and hence anti-viral effect of 4-{3-(subst.-amino)-2-hydroxypropoxy}-1,2,5-thiadiazole compounds
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU6010594A (en) * 1993-02-12 1994-08-29 Sankyo Company Limited Isoxazoleoxy derivative
ES2111197T3 (es) * 1993-04-21 1998-03-01 Tosoh Corp 3,4-dioxi-1,2,5-tiadiazoles en parte utiles como fungicidas.
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
UA43347C2 (uk) * 1993-08-19 2001-12-17 Ново Нордіск А/С Спосіб лікування психічних захворювань
SG55071A1 (en) * 1993-08-19 1998-12-21 Novo Nordisk As Antipsychotic method

Also Published As

Publication number Publication date
CA2161176A1 (en) 1996-04-25
TW420680B (en) 2001-02-01
US5821370A (en) 1998-10-13
US5672709A (en) 1997-09-30
US5929247A (en) 1999-07-27
CO4480103A1 (es) 1997-07-09
PL311077A1 (en) 1996-04-29
HU9503045D0 (en) 1995-12-28
US5646289A (en) 1997-07-08
NO954239D0 (no) 1995-10-23
US5821371A (en) 1998-10-13
NO954239L (no) 1996-04-25
AU705047B2 (en) 1999-05-13
BR9504509A (pt) 1997-05-27
TR199501305A2 (tr) 1996-06-21
CZ275995A3 (en) 1996-08-14
CN1145364A (zh) 1997-03-19
FI955051A (fi) 1996-04-25
NZ280300A (en) 1997-11-24
IL115717A0 (en) 1996-01-19
HUT76347A (en) 1997-08-28
US5665745A (en) 1997-09-09
NO306949B1 (no) 2000-01-17
CN1048986C (zh) 2000-02-02
PE12697A1 (es) 1997-04-24
AU3439695A (en) 1996-05-02
EP0709381A1 (en) 1996-05-01
RU2158262C2 (ru) 2000-10-27
KR960014125A (ko) 1996-05-22
JPH08225575A (ja) 1996-09-03
YU66895A (sh) 1998-09-18

Similar Documents

Publication Publication Date Title
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
EE03486B1 (et) Pürasool-4-üülbensoüüli derivaadid ja nende kasutamine herbitsiididena
FI955235A0 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
EP0788489A4 (en) HETEROCYCLIC COMPOUNDS AND THEIR USE
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
EE9900524A (et) N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena
ZA952410B (en) Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
FI964267A (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
PT755386E (pt) Derivado de benzamida composicoes contendo o referido derivado e sua utilizacao
FI953021A0 (fi) 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä
BR9509688A (pt) Composto e composição farmacêutica
FI970110A (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
FI935654A (fi) Kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
FI971317A (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
EE9800054A (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
IL114490A0 (en) Heterocyclic compounds their preparation and their use
FI964709A (fi) Kiraalisia yhdisteitä ja niiden resoluutio
BR9505130A (pt) Composto e composiçao farmacêutica
DE9405878U1 (de) Rhenchodepressive Substanz
FI951762A0 (fi) Substituoituja morfoliinijohdannaisia ja niiden käyttö terapeuttisina aineina